High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.
第一作者:
Giuseppe Maria,Milano
第一单位:
Division of Pediatric Oncology, Ospedale Pediatrico Bambino Gesù-IRCCS, Rome, Italy. milano_gm@hotmail.com
作者:
医学主题词
青少年(Adolescent);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);骨肿瘤(Bone Neoplasms);卡铂(Carboplatin);儿童(Child);儿童, 学龄前(Child, Preschool);环磷酰胺(Cyclophosphamide);无病生存(Disease-Free Survival);多柔比星(Doxorubicin);依托泊甙(Etoposide);人类(Humans);异环磷酰胺(Ifosfamide);婴儿(Infant);神经外胚瘤, 原始(Neuroectodermal Tumors, Primitive);存活率(Survival Rate);长春新碱(Vincristine)
DOI
10.1002/cncr.21780
PMID
16532434
发布时间
2015-11-19
- 浏览14
Cancer
1838-45页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



